Shardaben Gulabdas Patel submits disclosure

31 Mar 2018 Evaluate

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shardaben Gulabdas Patel.

The above information is a part of company’s filings submitted to BSE.

Lincoln Pharma Share Price

588.60 -3.05 (-0.52%)
28-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1841.80
Dr. Reddys Lab 1199.70
Cipla 1554.40
Lupin 2107.70
Zydus Lifesciences 885.85
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...